Exchange: NYSE·Updated 07:53 PM EDT
DHR logo

DHR Danaher Corp.

$219.81
$2.35
(1.08%)
Today
Closed $219.81
$0.1687
(0.08%)
After Hours
EarningsOct 21
Mkt Cap$152.87B
Vol3.93M

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
53

Neutral Sentiment

How do you feel about DHR?

astuteoptics1
$DHR Our framework on Danaher Corporation yields a bullish stance, with 8 of 9 matrix cells positive and an average conviction of 3.75 out of 5. As shown in the chart attached, the only neutral reading is long-term technical momentum after an extended drawdown. Across the rest of the grid, evidence is constructive: a second-quarter earnings beat paired with raised guidance anchors the near term, while abating headwinds benefit the intermediate horizon. Sentiment aligns as well, highlighted by a twenty percent decline in short interest alongside steady institutional backing, with price holding above the 200-day moving average. We would change our mind if renewed headwinds impair free cash flow or if price breaks below the 200-day average. This reflects our read as of 21 Sep 2026—a dated snapshot, not a live call. (Disclosure: we're and this is our own research.)
2
SunriseTrader
$DHR making a nice move today. A close over 209.50 what I am watching to get me to move up stops. Updated chart
1
thatsolardude365
$DHR payout watch: the $172.5M Danaher securities settlement had its final approval hearing Sept 3. Claims are closed; investors who filed are waiting on a ruling, with about $1.13 per share estimated. Open Class Actions.

Advertisement|Remove ads.